The upcoming virtual emergency scientific consultation on Andes Virus medical countermeasures (MCM) R&D is a crucial gathering of experts and stakeholders in the field of public health and infectious diseases. This event, organized by the WHO Research & Development Blueprint for Epidemics and the Bunyavirus Collaborative Open Research Consortium (CORC), is set to take place on May 15, 2026, from 13:00 to 16:00 Geneva time (CET).
The consultation comes at a critical time as the Andes virus situation continues to evolve, posing significant challenges to global health security. By bringing together leading experts, researchers, clinicians, public health authorities, funders, and partners, this rapid consultation aims to address the pressing need for coordinated research and MCM development.
The agenda for the consultation is comprehensive, covering key areas of focus:
- Current Epidemiological Developments and Transmission Dynamics: Understanding the latest trends in the virus's spread and its transmission patterns is crucial for effective prevention and control measures.
- Historical and Recent Evidence on Human-to-Human Transmission: Exploring the extent and mechanisms of human-to-human transmission will help in assessing the virus's potential for widespread outbreaks.
- Clinical Management and Natural History Studies: Gaining insights into the clinical course of the disease and the natural history of infections will inform the development of effective treatment strategies and patient care.
- Diagnostics, Therapeutic, and Vaccine MCM Landscapes: This section will delve into the current state of diagnostics, therapeutics, and vaccine development, identifying gaps and priorities for MCM enhancement.
The event promises to be a valuable platform for knowledge exchange and collaboration, offering a unique opportunity to accelerate research and MCM development for the Andes Virus. By bringing together diverse stakeholders, the consultation aims to catalyze coordinated efforts to combat this emerging public health threat.
In my opinion, this consultation is a testament to the global commitment to addressing emerging infectious diseases. It highlights the importance of rapid response and collaboration in the face of evolving health crises. As an expert in the field, I find it particularly fascinating that such a diverse group of professionals will come together to share their expertise and insights. This collaborative approach is essential for making significant strides in medical countermeasure development and ensuring the world is better prepared for future health emergencies.
